Best pharmaceutical companies in Durham, NC

5764914 Novartis International AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland.

Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock.

Aerie Pharmaceuticals, Inc., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of ophthalmic diseases. It focuses on the development of products for the pharmaceutical treatment of glaucoma. The company was founded in 2005 and is headquartered in Bridgewater, New Jersey with research facilities in Research Triangle Park, North Carolina. Aerie Pharmaceuticals, Inc. is a former subsidiary of Duke University Medical Center.

The Almac Group is an established contract development and manufacturing organisation that provides an extensive range of integrated services globally to companies within the pharmaceutical and biotech sectors. The services range from R&D, biomarker discovery and development, API manufacture, formulation development, clinical trial supply, IXRS technology (IVRS/IXRS) through to commercial-scale manufacture and companion diagnostic development.Only Almac can combine the expertise, from their specialised teams, to provide you with the right service solutions to help you across the full biopharmaceutical product lifecycle, from the preclinical stages through to commercialisation. They are a privately owned organisation that has organically grown over 40 years and now employs in excess of 4,500 highly skilled personnel. Almac is headquartered in Craigavon, Northern Ireland with operations in the UK, Ireland, across the US (Pennsylvania, North Carolina and California) and in Asia (Singapore and Tokyo). Through our continual investment in the development of our state of the art services; from cutting edge biomarker and companion diagnostics through to step changes in the management of the clinical trial data and the clinical supply chain to biocatalytic manufacture of API, Almac ensures they are always there to support you across the product development lifecycle.

Intarcia Therapeutics is a biopharmaceutical company that develops therapies for diseases that require long-term chronic treatment. It offers DUROS, a drug delivery platform that stabilizes and delivers therapeutic proteins and peptides. Intarcia Therapeutics' products include OMEGA DUROS, an interferon delivery device for treating Hepatitis C and ITCA 650, a delivery device that provides type 2 diabetes patients with long-term steady state dosing of an incretin mimetic therapy. Additionally, it develops programs for treating obesity. David Franklin, James M. Ahlers, and Thomas Alessi founded BioMedicines in 1997 that became Intarcia Therapeutics in September 2004. Its headquarters is in Hayward in California with an additional office in Mountain View in California.

Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases. The company is driven by a mission to discover, develop, and provide innovative products and services that save and improve lives around the world. Merck delivers vaccines, medications, and consumer and animal health products that can help millions around the world. Merck was founded in 1891 and is headquartered in Kenilworth, NJ.

Eli Lilly and Company is known for their high-quality medicines which are being distributed to 125 countries. Founded in 1876 by Col. Eli Lilly, this global pharmaceutical company remains committed to his vision through every aspect of their business and the people they serve, starting with those who take their medicines, and extending to health care professionals, employees and the communities in which they live. They currently have up to $1 billion in revenue and around 10,000 employees.

AstraZeneca is one of the world's leading pharmaceutical companies. It focuses on the discovery, development and commercialisation of prescription medicines. Its purpose is to deliver life-changing medicines by pushing the boundaries of science. AstraZenesa specializes in three main therapy areas Oncology, Cardiovascular & Metabolic Disease (CVMD) and Respiratory. The company operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Its headquarters in North America are located in Wilmington, DE, with additional locations in Gaithersburg, MD, and Boston, MA.

Ligand is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Ligand business model creates value for stockholders by providing a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. Ligand goal is to offer investors an opportunity to participate in the promise of the biotech industry in a profitable, diversified and lower-risk business than a typical biotech company. Ligand business model is based on doing what we do best: drug discovery, early-stage drug development, product reformulation and partnering. Ligand partner with other pharmaceutical companies to leverage what they do best (late-stage development, regulatory management and commercialization) to ultimately generate Ligand revenue.

Today's highly innovative biotech and specialty pharma companies are doing incredible things. It's amazing science, and we've positioned ourselves right in the middle of the action, targeting the therapeutic areas where these pioneers are doing the most exciting work. Their unparalleled experience in analgesia spans more than 850 trials and includes every NSAID painkiller sold today.

Covance Inc. is a global contract research organization recognized for being the world's most comprehensive drug development company. It has a team of professionals that are dedicated to advancing healthcare and delivering fast and innovative medical solutions to patients and healthcare providers. The company also offers laboratory testing services to the chemical, agrochemical, and food industries. It is also a market leader in central laboratory, toxicology, and discovery services.

Vertically integrated supply chain ensures unmatched quality & value for our customers. Our Products Who We Are News Social Responsibility Aurobindo's partnerships provide ongoing support in times of need. The pharmaceuticals that were donated have bee...

Certara is the leading biosimulation and regulatory writing consultancy, focused on optimizing and increasing the predictability of the most crucial R&D, regulatory and patient care decisions. We provide a wide range of products, services and solutions that enable our clients to achieve key drug development milestones. Our portfolio spans the discovery, preclinical, clinical and post-marketing phases of drug development, working with 1,200 commercial companies, 250 academic institutions and numerous regulatory agencies.

Cambrex is a small molecule company that offers drug substance, drug product, and analytical services. The company provides an end-to-end partnership for the research, development, and manufacture of small molecule therapeutics at every stage of the lifecycle. With years of experience and a growing team of experts servicing global clients, the company is tried and trusted in branded and generic markets for API and dosage form development and manufacturing. It was founded on 1981 and is headquartered in East Rutherford, New Jersey.

Eurofins is an international group of laboratories headquartered in Luxembourg, providing testing and support services to the pharmaceutical, food, environmental, agriscience and consumer products industries and to governments.

Charles River Laboratories International, Inc. provides solutions that accelerate the drug discovery and development process, including research models and associated services, and outsourced preclinical services. Segments The company has two segments: Research Models and Services (RMS) and Preclinical Services (PCS), which includes Phase I clinical services. RESEARCH MODELS AND SERVICES (RMS) The company supplies research models to the drug development industry. With approximately 150 different strains the company engages in the production and sale of research models, principally genetically and virally defined purpose-bred rats and mice. It also provides various related services that are designed to assist customers in supporting the use of research models in drug development. With multiple facilities located on three continents (North America, Europe and Asia (Japan)), the company maintains production centers, including a total of approximately 180 barrier rooms or isolator facilities located near its customers. RMS segment comprises Research Models, Research Model Services, and other related products and services

Clearside BioMedical, an ophthalmic company, specializes in the research, development, and commercialization of therapeutic products through an ocular microinjection platform that targets the individual compartments of the eye. It provides a non-surgical application for dosing drugs to distinct eye tissues, such as retina, trabecular meshwork, and corneal stroma. The company's CLS1001 is under development for retinal applications through the delivery of therapeutics to the suprachoroidal space. Clearside BioMedical was incorporated in 2011 and is based in Atlanta, Georgia.

Grifols is a global healthcare company. Grifols operates in three segments: Bioscience, Hospital, and Diagnostic. The Bioscience segment engages in the research, development, production, and commercialization of plasma derivates. The Diagnostic segment focuses on researching, developing, manufacturing, and marketing diagnostics products for laboratory analysis, including products for hospital blood banks and transfusion centers.

Alcami is a leading contract development and manufacturing organization that offers customized solutions for small and mid-sized pharmaceutical and biotechnology companies. The company has two well-equipped laboratories located in Durham and Wilmington, North Carolina offering all phases of pharmaceutical drug product development for small and large molecules. It currently has over 1,000 employees operating at ten global locations.